AMG has done a lot with the CLE to make it truly special, providing satisfaction to lovers of driving, style, opulence, and ...

Researchers at Hospital for Special Surgery (HSS) have uncovered a critical link between the immune system in early life and ...

A new treatment platform developed by researchers at the University of Texas MD Anderson Cancer Center was able to deliver messenger RNA (mRNA) of the full-length DMD gene into preclinical models of ...

Duchenne muscular dystrophy (DMD) is caused by a mutation in the DMD gene that prevents dystrophin production, leading to progressive muscle weakness and early mobility challenges. The 2018 DMD ...

This study reveals abnormal iron accumulation in the muscles of patients with Facioscapulohumeral Muscular Dystrophy (FSHD) and in mice expressing muscle-specific DUX4 (DUX4-Tg mice). Contrary to ...

With a $298 million series B round, Function Health has now hit unicorn status with a $2.5 billion valuation. (Arkadiusz Warguła/GettyImages) Function Health, a startup that offers lab testing and ...

To open and view the System Information panel in Windows 11/10, you can use any of the following ways: You can also open the elevated System Information panel by clicking on the Run as administrator ...

The least-squares mean difference in the Hammersmith Functional Motor Scale-Expanded change from baseline at 12 months was 1.8 points for those 2 to 12 years receiving apitegromab vs placebo.

New research has identified the enzyme glutamate dehydrogenase 1 (GLUD1) as a new therapeutic target for Duchenne muscular dystrophy (DMD). In preclinical DMD mouse models, investigators demonstrated ...

Findings published in The American Journal of Pathology identify GLUD1 enzyme as a potential therapeutic target for muscle restoration through metabolic reprogramming, addressing clinically unmet need ...